Ajanta Pharma Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.066x

Ajanta Pharma Limited cash flow conversion efficiency. Based on the latest financial reports, Ajanta Pharma Limited (AJANTPHARM) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.84 Billion ≈ $30.71 Million USD) by net assets (Rs43.15 Billion ≈ $466.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Ajanta Pharma Limited (2005–2025)

Cash flow conversion efficiency of Ajanta Pharma Limited from 2005 to 2025. This chart illustrates how Ajanta Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Ajanta Pharma Limited for real-time trading data and today's change.

Ajanta Pharma Limited Cash Flow Conversion Ratio Explained

Ajanta Pharma Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Ajanta Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ajanta Pharma Limited ranked by their cash flow conversion efficiency. Also see Ajanta Pharma Limited stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
3SBio Inc F:83B	0.019x
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	-0.026x
GEM CO. LTD SP.GDR/10 A F:3730	N/A
Perimeter Solutions SA NYSE:PRM	0.000x
Lifestance Health Group Inc NASDAQ:LFST	0.068x
Tamarack Valley Energy Ltd TO:TVE	0.124x
Huadian Energy SHG:600726	0.009x
Sinolink Securities Co Ltd SHG:600109	0.480x

Annual Cash Flow Conversion Efficiency for Ajanta Pharma Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Ajanta Pharma Limited from 2005 to 2025. Review Ajanta Pharma Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs37.90 Billion ≈ $409.91 Million	Rs11.57 Billion ≈ $125.15 Million	0.305x	+38.73%
2024-03-31	Rs35.67 Billion ≈ $385.80 Million	Rs7.85 Billion ≈ $84.90 Million	0.220x	-5.83%
2023-03-31	Rs33.88 Billion ≈ $366.40 Million	Rs7.92 Billion ≈ $85.63 Million	0.234x	+35.73%
2022-03-31	Rs32.64 Billion ≈ $353.03 Million	Rs5.62 Billion ≈ $60.78 Million	0.172x	-10.50%
2021-03-31	Rs29.96 Billion ≈ $323.97 Million	Rs5.76 Billion ≈ $62.33 Million	0.192x	+9.46%
2020-03-31	Rs25.99 Billion ≈ $281.06 Million	Rs4.57 Billion ≈ $49.40 Million	0.176x	+5.29%
2019-03-31	Rs22.45 Billion ≈ $242.81 Million	Rs3.75 Billion ≈ $40.53 Million	0.167x	+19.39%
2018-03-31	Rs20.41 Billion ≈ $220.77 Million	Rs2.85 Billion ≈ $30.87 Million	0.140x	-63.95%
2017-03-31	Rs15.68 Billion ≈ $169.54 Million	Rs6.08 Billion ≈ $65.76 Million	0.388x	+39.29%
2016-03-31	Rs11.72 Billion ≈ $126.75 Million	Rs3.26 Billion ≈ $35.30 Million	0.278x	-16.18%
2015-03-31	Rs8.41 Billion ≈ $90.96 Million	Rs2.79 Billion ≈ $30.22 Million	0.332x	-7.21%
2014-03-31	Rs5.93 Billion ≈ $64.16 Million	Rs2.12 Billion ≈ $22.97 Million	0.358x	-40.32%
2013-03-31	Rs3.93 Billion ≈ $42.51 Million	Rs2.36 Billion ≈ $25.50 Million	0.600x	+133.59%
2012-03-31	Rs2.98 Billion ≈ $32.23 Million	Rs765.41 Million ≈ $8.28 Million	0.257x	-41.57%
2011-03-31	Rs2.29 Billion ≈ $24.75 Million	Rs1.01 Billion ≈ $10.88 Million	0.440x	-14.54%
2010-03-31	Rs1.85 Billion ≈ $20.00 Million	Rs951.16 Million ≈ $10.29 Million	0.514x	+133.60%
2009-03-31	Rs1.57 Billion ≈ $16.99 Million	Rs345.92 Million ≈ $3.74 Million	0.220x	+55.96%
2008-03-31	Rs1.35 Billion ≈ $14.62 Million	Rs190.81 Million ≈ $2.06 Million	0.141x	-22.80%
2007-03-31	Rs1.16 Billion ≈ $12.50 Million	Rs211.30 Million ≈ $2.29 Million	0.183x	-21.67%
2006-03-31	Rs1.09 Billion ≈ $11.74 Million	Rs253.45 Million ≈ $2.74 Million	0.233x	+446.42%
2005-03-31	Rs978.24 Million ≈ $10.58 Million	Rs-65.93 Million ≈ $-713.01K	-0.067x	--

About Ajanta Pharma Limited

NSE:AJANTPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$4.59 Billion

Rs424.32 Billion INR

Market Cap Rank

#3651 Global

#159 in India

Share Price

Rs3396.30

Change (1 day)

-3.21%

52-Week Range

Rs2458.10 - Rs3718.20

All Time High

Rs3718.20